Eli Lilly & Co. (LLY) Tops Q2 EPS by 1c; Raises, Narrows FY11 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq edge higher ahead of midterm results; Apple falls
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts LLY Hot Sheet
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q2 EPS of $1.18, $0.01 better than the analyst estimate of $1.17. Revenue for the quarter came in at $6.25 billion versus the consensus estimate of $5.99 billion.
Eli Lilly & Co. sees FY2011 EPS of $4.25-$4.35, versus the consensus of $4.28.
Eli Lilly & Co. sees FY2011 EPS of $4.25-$4.35, versus the consensus of $4.28.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Eli Lilly (LLY) PT Raised to $1,600 at RBC Capital After an 'Impressive Quarter'
- AdaptHealth Corp. (AHCO) Misses Q3 EPS by 120c ; Offers Guidance
- Fiserv Inc (FISV) Tops Q3 EPS by 3c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
